-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CST-101 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CST-101 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CST-101 in Parkinson's Disease Drug Details: CST-10 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CST-2140 in Orthostatic Hypotension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CST-2140 in Orthostatic Hypotension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CST-2140 in Orthostatic Hypotension Drug Details: CST-2140 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + Nadolol) in Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (CST-2032 + Nadolol) in Dementia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (CST-2032 + Nadolol) in Dementia Drug Details: A fixed-dose combination...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CST-109 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CST-109 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CST-109 in Parkinson's Disease Drug Details: CST-109 is under development for the...
-
Analyst Opinions
NewTunnel Construction Project Insights and Analytics (Q1 2024)
Tunnel Construction Projects Report Overview The total value of tunnel construction projects is $1.1 trillion in Q1 2024 at all stages of development from announcement to execution. Various governments across the world are restricting investments in public infrastructure to control rising budget deficits. The budget constraints will restrain new investment in tunnel construction, as a substantial proportion of such demand is reliant on the development of public infrastructure. The tunnel construction projects research report provides analysis based on GlobalData's construction...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + Nadolol) in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (CST-2032 + Nadolol) in Mild Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (CST-2032 + Nadolol) in Mild Cognitive Impairment Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TI-1007 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TI-1007 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TI-1007 in B-Cell Non-Hodgkin Lymphoma Drug Details: TI-1007 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRG-022 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRG-022 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRG-022 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy 2...